Rezolute, Inc.
Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibod…
Biotechnology
US, Redwood City [HQ]
Insiders
Transactions
Track non-derivative insider transactions.
i = Indirect Ownership
d = Direct Ownership
cs = Common Stock
Reported Owner(s) | Position Now | Transaction Date | Type | Position Change | Extra |
---|
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture: